Application Review Schedule for SHINE Medical Technologies, LLC Operating License
SHINE Medical Technologies, LLC submitted an
operating license application for a medical radioisotope facility. The following table summarizes the U.S. Nuclear Regulatory Commission's key milestones for reviewing this application.
Key Milestones |
Completion Date
Actual—A
Target—T |
Application Tendered |
Receipt of Operating License Application
|
08/2019—A |
Acceptance Review |
Acceptance of Application for Docketing
|
10/2019—A |
Federal Register Notice |
Issuance of Notice of Opportunity to Request Hearing
|
01/2020—A |
Closing of Opportunity to Request Hearing
|
03/2020—A |
Environmental Review Schedule |
Environmental Scoping Meeting
|
12/2019—A |
NUREG Publication of Supplemental Draft Environmental Impact Statement
|
06/2022—A |
NUREG Publication of Supplement Final Environmental Impact Statement
|
02/2023—A |
Safety Review Schedule |
Draft Safety Evaluation Report
|
11/2022—A |
Final Safety Evaluation Report
|
02/2023—A |
Advisory Committee on Reactor Safeguards (ACRS) |
ACRS Subcommittee Meeting
|
03/2022—A |
ACRS Subcommittee Meeting
|
05/2022—A |
ACRS Subcommittee Meeting
|
07/2022—A |
ACRS Subcommittee Meeting
|
09/2022—A |
ACRS Full Committee Meeting
|
11/2022—A |
Construction Inspection |
Notification of Substantial Completion of Construction
|
TBD |
Hearing |
Contested Hearing on Issuance of Operating License
|
No Petitions for Hearing Received by Deadline |
License |
Determination on Whether to Issue Operating License
|
TBD |
First Production
|
2024 |